Prurigo Nodularis
📧 Sign up to get email alerts when something new happens for Prurigo Nodularis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Study on the Treatment of Prurigo Nodularis With Stapokibart Injection [Phase 3]
A Phase 3 clinical trial evaluating stapokibart injection for prurigo nodularis has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis [Phase 2]
Phase 2 study evaluating the efficacy, safety, and tolerability of vixarelimab in reducing pruritus for patients with prurigo nodularis has …
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of ruxolitinib cream in prurigo nodularis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) [Phase 3]
Phase 3 trial evaluating the safety and efficacy of ruxolitinib topical cream for prurigo nodularis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating the safety and tolerability of maximal-use ruxolitinib cream…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: PRISM Study-Pruritus Relief Through Itch Scratch Modulation [Phase 2, Phase 3]
The PRISM study evaluated pruritus relief through itch-scratch modulation in prurigo nodularis and has completed Phase 2/3. Results have bee…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Efficacy of Topical Cannabidiol for Eczema [Phase 2]
A Phase 2 clinical trial sponsored by Khon Kaen University is evaluating the efficacy of a topical cannabidiol formulation for eczema-relate…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis [Phase 3]
Phase 3 clinical trial of MG-K10, a humanized monoclonal antibody injection, for prurigo nodularis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis [Phase 3]
Phase 3 trial evaluating the durability of response and safety of nemolizumab for 24 weeks in participants with prurigo nodularis; results h…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis [Phase 2]
Phase 2 study evaluating the efficacy and safety of INCB054707 in Prurigo Nodularis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) [Phase 3]
Phase 3 study evaluating nemolizumab for prurigo nodularis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) [Phase 3]
Phase 3 trial data evaluate the efficacy and safety of nemolizumab in participants with prurigo nodularis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin [Phase 2]
Phase 2 trial update on abrocitinib showing efficacy in reducing pruritus in adults with prurigo nodularis and chronic pruritus of unknown o…
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME) [Phase 3]
Phase 3 trial results update for dupilumab in prurigo nodularis (LIBERTY-PN PRIME) has been completed with results posted in December 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) [Phase 3]
Phase 3 PRIME2 evaluated dupilumab for prurigo nodularis inadequately controlled on topical therapies. The study status is completed with re…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN) [Phase 2]
A Phase 2 randomized, placebo-controlled trial of serlopitant (NK1 receptor antagonist) in prurigo nodularis has completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) [Phase 3]
Phase 3 long-term safety study of serlopitant for pruritus was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis [Phase 3]
Phase 3 trial investigating serlopitant for pruritus associated with prurigo nodularis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis [Phase 2, Phase 3]
Open-label extension study of nalbuphine HCl ER in patients with prurigo nodularis has completed, with results posted in October 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis [Phase 3]
Phase 3 trial evaluating serlopitant for pruritus associated with prurigo nodularis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluated nalbuphine HCl extended-release tablets for prurigo nodularis, with results posted in A…
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Safety and Efficacy of Nemolizumab in PN [Phase 2]
Phase 2 clinical trial update assessing safety and efficacy of nemolizumab in prurigo nodularis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial update evaluating apremilast as an anti-pruritic treatment for prurigo nodularis.
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Safety and Efficacy of CC-10004 for Prurigo Nodularis [Phase 2]
Phase 2 trial evaluating CC-10004 for prurigo nodularis has completed, with safety and efficacy results reported.
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease [Phase 2]
Phase 2 trial results evaluate the antipruritic effect of topical pimecrolimus (Elidel) in non-atopic pruritic disease (Prurigo Nodularis). …